|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4152 | |
| A61P 25/00 |
| (11) | Patento numeris | 1793821 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05772671.3 |
| Europos patento paraiškos padavimo data | 2005-08-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-06-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2005/014969 |
| Data | 2005-08-10 |
| (87) | Numeris | WO 2006/016707 |
| Data | 2006-02-16 |
| (30) | Numeris | Data | Šalis |
| 2004233635 | 2004-08-10 | JP |
| (72) |
YUKI, Satoshi, c/o MITSUBISHI PHARMA CORPORATION, JP
NAKANO, Takuma, c/o MITSUBISHI PHARMA CORPORATION, JP
SUZUKI, Hiroko, c/o MITSUBISHI PHARMA CORPORATION, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
2-10, Dosho-machi 3-chome Chuo-ku, Osaka-shi Osaka 541-8505,
JP
|
| (54) | PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS |
| PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS |